Finance
Markets
No recent trading data. The last price we hold for IDXX is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

IDXX

stock Healthcare Diagnostics & Research
Idexx Laboratories
$560.73 +9.91 (+1.80%) Delayed · quoted 47d ago
Healthy 63% Climbing

What the indicators say

Mixed 1 of 5 trend signals bullish
Momentum · RSI 14 Neutral
51
0oversold 30overbought 70100

RSI 51 — momentum is balanced between buyers and sellers.

EMA 21 $557.00
Above
Near-term trend is up
SMA 50 $563.47
Below
Medium-term trend is down
SMA 200 $636.80
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $586.82
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $547.57 High $561.65
Open
$560.73
+1.80%
Close
$560.73
+1.80%
52-week range where the price sits across its year
52w low $506.91 52w high $769.98
Current
$560.73
Prev close
$550.82
Volume 1.5× the 3-month average
0 avg 2× avg
Today
869.87K
3-mo avg
580.71K

Earningscalendar synced from Yahoo 57d ago

Most recent
May 577 days ago
Next expected
Aug 3in 13 days

Recent earnings dates

  • May 5 77 days ago
  • Feb 2 169 days ago
  • Nov 3, 2025 260 days ago
  • Aug 4, 2025 351 days ago

Past earnings dates come from IDXX’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), IDXX’s fundamentals read as strong overall.

P/E ratio Weak
41.3x

At 41.3x, the price is steep relative to profit; the stock leans heavily on growth that has yet to arrive.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Strong
24.6%

A 24.6% margin is strong; the company keeps a healthy slice of every revenue dollar.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong
66.0%

A 66.0% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Strong
31.6%

A 31.6% return on assets is strong; the company squeezes good profit from its assets.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Fair
1.09

At 1.09, the company carries a moderate, manageable amount of debt.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.23

At 1.23, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Strong
+10.4%

Revenue grew 10.4% from the prior year: strong top-line expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Strong
+19.3%

Net income grew 19.3% from the prior year: strong profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $3.2B$3.4B$3.7B$3.9B$4.3B
Net income $744.8M$679.1M$845.0M$887.9M$1.1B
Diluted EPS $8.60$8.03$10.06$10.67$13.08
Dividend / share —————
Total assets $2.4B$2.7B$3.3B$3.3B$3.4B
Total liabilities $1.7B$2.1B$1.8B$1.7B$1.7B
Shareholder equity $690.0M$608.7M$1.5B$1.6B$1.6B

Leadershipsynced from SEC 56d ago

  • Britt Irene Chang Director
  • Claflin Bruce L. Director
  • Essig Stuart Director
  • Hooley Joseph L Director
  • Junius Daniel M Director
  • Kingsley Lawrence D Director
  • Peacock Karen Director
  • Samad Sam Director
  • Vandebroek Sophie V. Director

Officers and board are drawn from IDXX’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved